United States

Zhejiang Huahai Pharmaceutical Co Ltd (600521.SS)

600521.SS on Shanghai Stock Exchange

8:41pm EST
Change (% chg)

¥0.07 (+0.33%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low


Chart for 600521.SS


ZHEJIANG HUAHAI PHARMACEUTICALCO.,LTD is a China-based company principally engaged in the manufacture and distribution of pharmaceutical active pharmaceutical ingredients (APIs), intermediates and preparations. The Company's main products are classified as -pril series, -sartan series and preparations, including irbesartan... (more)


Beta: 0.76
Market Cap(Mil.): ¥21,883.34
Shares Outstanding(Mil.): 1,042.56
Dividend: 0.15
Yield (%): 0.73


  600521.SS Industry Sector
P/E (TTM): 43.00 28.84 29.63
EPS (TTM): 0.49 -- --
ROI: 11.99 13.44 12.96
ROE: 13.14 14.34 14.11

BRIEF-Zhejiang Huahai Pharmaceutical unit gets FDA approval

* Says its unit Prinston Pharmaceutical, Inc received U.S FDA approval for a broad spectrum antibiotic tablet

Nov 21 2016

BRIEF-Zhejiang Huahai Pharmaceutical gets nod for clinic trial

* Says it gets China Food and Drug Administration's approval for clinic trial of a capsule used for treatment of depression

Nov 03 2016

BRIEF-Zhejiang Huahai Pharmaceutical to set up medical health investment management JV

* Says it to set up a medical health investment management JV with a Shanghai-based fund management firm

Oct 14 2016

More From Around the Web

Earnings vs. Estimates